Redefining Treatment for Golfers Suffering with Knee Osteoarthritis

Knee osteoarthritis (OA) is the most prevalent type of arthritis, impacting millions globally. Golfers, in particular, are prone to knee OA, as the average round of golf covers over six miles, causing severe knee agony. However, golfers coping with this issue now have new hope thanks to Arthrosamid®, a novel injectable medication that provides long-term relief from knee OA discomfort – even three years post treatment. (2-5). Arthrosamid® is the first permanent injectable solution for knee osteoarthritis, designed to significantly reduce pain and improve mobility for those struggling with this condition.

What the experts say

Mr Amir Qureshi, a specialist knee surgeon at University Hospital Southampton and Spire Southampton, is committed to innovative interventions that avoid or delay an eventual knee replacement.


Mr Amir Qureshi

He shares his opinions about this innovative treatment: 

“I’m excited to be offering patients the Arthrosamid® treatment. In contrast to other treatments, Arthrosamid® appears to be offering patients long-lasting respite from the pain and immobility of knee osteoarthritis and, in many cases, avoiding or delaying the need for surgery. I believe it’s setting a real benchmark in injectables for osteoarthritis of the knee, offering hope and optimism to many of those living with this condition.”

Mr Miller, who runs the Early Arthritis Research Clinic in collaboration with Cardiff University’s Arthritis Research UK Biomechanics and Bioengineering Centre, adds:

Mr Andrew Miller

“For many, knee osteoarthritis really is a debilitating condition, which can prevent people from taking part in the hobbies and pastimes they love, whether gardening, golf or walking the dog – as well as not being able to go to work or run around with the grandchildren without pain. We really have been waiting for an innovation such as this and the prospect of a new treatment option which will provide patients with an alternative to invasive surgery – I’ve  treated a number of golfers – in their early 60s – who were keen to get back on course as soon as possible and the results have been really encouraging.”

Patient story

When keen golfer Nick, 61, felt a ‘ping’ in his right knee while playing golf about 18 months ago, he feared he might finally have to undergo knee replacement surgery. He’d been avoiding it for more than a decade as he knew there was a slow recovery time.

He treated his discomfort with pain relievers and cold packs until his knee deteriorated to the point that daily activities became challenging. In early 2023, Nick sought Arthrosamid® injections from a Cardiff-based consultant.

Not only had the pain totally disappeared, but I was also no longer feeling any stiffness in my knee joint,” says Nick. “I hadn’t experienced as much movement and flexibility in 25 years. In my opinion, the results are nothing short of a miracle. It’s no exaggeration to say that it can give you back your life particularly if a large part revolves around playing golf.”

How Does Arthrosamid® Work?

Arthrosamid® is a hydrogel made up of 2.5 per cent cross-linked polyacrylamide and 97.5 per cent water. Arthrosamid ® combines with the synovial tissue in the knee to form a permanent scaffold, (6) and it’s this unique characteristic that provides a significant reduction in OA pain over a period (2-5) — with one single treatment.(7)

To book an appointment: 

To learn more or to book a consultation, contact:

  • Mr. Qureshi in Southampton: 02380914505 / Kate.England@spirehealthcare.com
  • Mr. Miller in Cardiff: Info@millerorthopaedics.co.uk / St Joseph’s Hospital, Newport: 01633 820 344 / Pro Sport Medicine, Cardiff: 02920762000

For more information about Arthrosamid®, visit: arthrosamid.com.

References:

  1. Neogi, T. ‘The epidemiology and impact of pain in osteoarthritis.’ Osteoarthritis and cartilage vol. 21,9 (2013): 1145-53. doi:10.1016/j.joca.2013.03.018 (2)
  2. Bliddal, H, Overgaard, A, Hartkopp, A et al. (2021) Polyacrylamide Hydrogel Injection for Knee Osteoarthritis: A 6 Months Prospective Study. Journal of Orthopedic Research and Therapy, 6 (2). 1188. ISSN 2575-8241 (1)
  3. Bliddal H, Beier J, Hartkopp A, Conaghan PG, Henriksen M,. One-year performance of polyacrylamide hydrogel vs. hyaluronic acid: A randomised controlled study. Poster presented at OARSI 2022. (23)
  4. Henriksen, M. et al. (2023). 3 year results from a prospective study of polyacrylamide hydrogel for knee osteoarthritis.. Osteoarthritis and Cartilage, 31(5), P682–683. doi:10.1016/j.joca.2023.02.023. (26)
  5. Bliddal et al. 3 year follow-up from a randomized controlled trial of intra-articular polyacrylamide hydrogel injection in subjects with knee osteoarthritis. Poster LB-31, OARSI 2024 World Congress on Osteoarthritis. (27)
  6. Arthrosamid®, Information for use. Release date March 2022 10082-003. (12)
  7. Christensen, L., Daugaard, S., 2016. Histological Appearance of the Synovial Membrane after Treatment of Knee Osteoarthritis with Polyacrylamide Gel Injections: A Case Report. Journal of Arthritis 5, 217. (15)


, ,